Related Experiment Video

Updated: May 22, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

The BATTLE trial: a bold step toward improving the efficiency of biomarker-based drug development

Eric H Rubin1, Keaven M Anderson, Christine K Gause

  • 1Merck Research Laboratories, North Wales, Pennsylvania 19454, USA. eric_rubin@merck.com

Cancer Discovery
|May 16, 2012
PubMed

Insights

The Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial successfully advanced targeted lung cancer therapy. This trial integrated diagnostics to identify patients who will benefit most from new treatments.

Area of Science:

  • Oncology
  • Clinical Trials
  • Biomarker Discovery

Background:

  • Lung cancer treatment requires novel therapeutic strategies.
  • Identifying patient subgroups likely to respond to targeted therapies is crucial.
  • Simultaneous development of therapeutics and diagnostics improves clinical trial efficiency.

Purpose of the Study:

  • To report the successful completion of the Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial.
  • To highlight advancements in clinical trial design for targeted lung cancer therapies.
  • To emphasize the integration of diagnostic tests with novel therapeutics.

Main Methods:

  • The BATTLE trial integrated biomarker analysis with targeted therapy development.
  • Diagnostic tests were developed in parallel with therapeutic agents.
  • Patient selection was based on identified biomarkers.

Main Results:

  • Successful completion of the BATTLE trial signifies a milestone in lung cancer research.
  • The trial demonstrated the feasibility of integrating biomarker-driven approaches into clinical trials.
  • This approach facilitates the identification of patient populations most likely to benefit from specific therapies.

Conclusions:

  • The BATTLE trial represents a significant advancement in optimizing targeted therapy for lung cancer.
  • Integrating diagnostics with therapeutics improves the precision of cancer treatment.
  • This model enhances the development and application of personalized medicine in oncology.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Cost-Efficient Transcriptomic-Based Drug Screening06:40

Cost-Efficient Transcriptomic-Based Drug Screening

Published on: February 23, 2024

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...